Dwyer K J, Pardridge W M
Department of Medicine, University of California School of Medicine, Los Angeles 90024.
Endocrinology. 1993 Feb;132(2):558-65. doi: 10.1210/endo.132.2.8093876.
The transport of glucose across the brain capillary endothelium, which makes up the blood-brain barrier (BBB) in vivo, is developmentally up-regulated in the postnatal period, as the brain switches from combustion of circulating ketone bodies to glucose. The principle transporter mediating the uptake of circulating glucose across the BBB is the GLUT1 isoform. To further define molecular mechanisms underlying developmental modulation of the BBB GLUT1 transporter, the amounts of brain microvessel GLUT1 mRNA and immunoreactive protein were quantitated. In addition, an immunocytochemical analysis of GLUT1 expression at the choroid plexus in developing brain was performed, since this transporter isoform is selectively expressed at the choroid plexus epithelium basolateral membrane. Quantitative Western blotting employing purified human erythrocyte glucose transporter as an assay standard showed that the concentration of immunoreactive GLUT1 protein in 70-day-old rabbit brain microvessels (111 +/- 3 pmol/mg protein) was not significantly different from the concentration of D-glucose-displaceable cytochalasin-B-binding sites (102 +/- 25 pmol/mg protein). Thus, GLUT1 is the principle isoform mediating glucose transport across the developing BBB. Quantitative Western blotting was performed on microvessels isolated from brains of rabbits on postnatal days 1, 14, 28, and 70. The concentrations of immunoreactive microvessel GLUT1 at these four stages of development were 13 +/- 2, 4 +/- 1, 49 +/- 2, and 111 +/- 3 pmol/mg protein, respectively. Capillary depletion analysis showed that essentially all of brain GLUT1 mRNA arises from the microvascular fraction, and Northern analysis of 10 micrograms poly(A)+ RNA from brains of rabbits 1, 14, 28, and 70 days postnatally showed a preferential stabilization of the GLUT1 mRNA compared to mRNA for two cytoskeletal proteins, actin and tubulin. Immunocytochemical analysis of immunoreactive GLUT1 in choroid plexus epithelia showed the following developmental modulation of the transporter protein: 1 day < 14 days < 28 days > 70 days. The concentration of immunoreactive GLUT1 at the basolateral membrane of choroid plexus epithelium at 28 days was much greater than the immunostaining of rabbit brain microvessels at the corresponding age. In conclusion, these studies show that immunoreactive GLUT1 protein initially undergoes down-regulation between birth and 14 days and then undergoes marked up-regulation between 14 and 70 days. Conversely, the concentration of GLUT1 mRNA is virtually unchanged in brain of rabbits at 70 vs. 14 days postnatally. These combined data suggest that a principle mechanism underlying the developmental regulation of GLUT1 at the BBB may be posttranscriptional.
葡萄糖穿过构成体内血脑屏障(BBB)的脑毛细血管内皮细胞的转运,在出生后阶段随着大脑从利用循环酮体转向利用葡萄糖而在发育过程中上调。介导循环葡萄糖穿过血脑屏障摄取的主要转运体是GLUT1异构体。为了进一步确定血脑屏障GLUT1转运体发育调节的分子机制,对脑微血管GLUT1 mRNA和免疫反应性蛋白的量进行了定量。此外,对发育中大脑脉络丛中GLUT1表达进行了免疫细胞化学分析,因为这种转运体异构体在脉络丛上皮细胞基底外侧膜上选择性表达。以纯化的人红细胞葡萄糖转运体作为测定标准的定量蛋白质印迹法显示,70日龄兔脑微血管中免疫反应性GLUT1蛋白的浓度(111±3 pmol/mg蛋白)与D-葡萄糖可置换的细胞松弛素B结合位点的浓度(102±25 pmol/mg蛋白)无显著差异。因此,GLUT-1是介导葡萄糖穿过发育中的血脑屏障转运的主要异构体。对出生后第1、14、28和70天的兔脑分离的微血管进行了定量蛋白质印迹分析。在这四个发育阶段,免疫反应性微血管GLUT1的浓度分别为13±2、4±1、49±2和111±3 pmol/mg蛋白。毛细血管耗竭分析表明,基本上所有脑GLUT1 mRNA都来自微血管部分,对出生后1、14、28和70天的兔脑提取的10μg聚腺苷酸加尾RNA进行的Northern分析显示,与两种细胞骨架蛋白肌动蛋白和微管蛋白的mRNA相比,GLUT1 mRNA有优先稳定化。脉络丛上皮细胞中免疫反应性GLUT1的免疫细胞化学分析显示了该转运蛋白的以下发育调节:1天<14天<28天>70天。28天时脉络丛上皮细胞基底外侧膜上免疫反应性GLUT1的浓度远高于相应年龄兔脑微血管的免疫染色。总之,这些研究表明,免疫反应性GLUT1蛋白最初在出生至14天之间下调,然后在14至70天之间显著上调。相反,出生后70天与14天相比,兔脑GLUT1 mRNA的浓度基本不变。这些综合数据表明,血脑屏障处GLUT1发育调节的主要机制可能是转录后机制。